BMS-986517

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986517, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]